EUVIMEDEUVIMED entdecken
VergleichsstudieÄquivalenzstudieRandomisierte kontrollierte Studie

Pharmacokinetic, bioequivalence, and safety assessments of two brands of 30-mg nifedipine controlled-release formulations in Chinese healthy subjects

Huan Lu, Fei Zhou, Cuijie Rui, Hen You, Wenhao Zhang, Yaxin Zhang, Juefang Ding, Shunbo Zhao, Qiang Wu

Int. Journal of Clinical Pharmacology and Therapeutics · 2024

DOI: 10.5414/cp204605 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Int. Journal of Clinical Pharmacology and Therapeutics, 2024. Verfasst von Huan Lu und 8 weiteren Autor:innen. Hauptthemen laut MEDLINE: Calcium Channel Blockers, Delayed-Action Preparations, Nifedipine, Postprandial Period.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Calcium Channel BlockersDelayed-Action PreparationsNifedipinePostprandial PeriodAdultFemaleHumansMaleYoung AdultAdministration, OralArea Under CurveAsian PeopleChinaChromatography, LiquidFastingFood-Drug InteractionsHealthy VolunteersTabletsTandem Mass SpectrometryTherapeutic Equivalency

Substanzen

Calcium Channel BlockersDelayed-Action PreparationsNifedipineTablets

Zitieren

APA

Lu, H., Zhou, F., Rui, C., You, H., Zhang, W., Zhang, Y., Ding, J., Zhao, S., & Wu, Q. (2024). Pharmacokinetic, bioequivalence, and safety assessments of two brands of 30-mg nifedipine controlled-release formulations in Chinese healthy subjects. Int. Journal of Clinical Pharmacology and Therapeutics. https://doi.org/10.5414/cp204605

Vancouver

Lu H, Zhou F, Rui C, You H, Zhang W, Zhang Y, et al. Pharmacokinetic, bioequivalence, and safety assessments of two brands of 30-mg nifedipine controlled-release formulations in Chinese healthy subjects. Int. Journal of Clinical Pharmacology and Therapeutics. 2024. doi:10.5414/cp204605

BibTeX
@article{Lu2024,
  author = {Lu, Huan and Zhou, Fei and Rui, Cuijie and You, Hen and Zhang, Wenhao and Zhang, Yaxin and Ding, Juefang and Zhao, Shunbo and Wu, Qiang},
  title = {Pharmacokinetic, bioequivalence, and safety assessments of two brands of 30-mg nifedipine controlled-release formulations in Chinese healthy subjects},
  journal = {Int. Journal of Clinical Pharmacology and Therapeutics},
  year = {2024},
  doi = {10.5414/cp204605}
}
Kostenlos starten →